| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
-, ß-, and
-Interferon: Differential Enhancement of Murine
-Interferon1
Department of Microbiology, The University of Texas Medical Branch, Galveston, Texas 77550 [W. R. F., C. M. F.], and Laboratory of Experimental Pathology, National Cancer Institute, Frederick Cancer Research Facility, Frederick, Maryland 21701 [T. D. G.]
Fever is frequently an important side effect of interferon (IFN) therapy. Studies have shown that culturing interferon-treated cells at elevated temperature heightens the antiproliferative activity of IFN-
and IFN-ß. Since IFN-
has also been shown to be a potent antiproliferative agent, the effect of elevated temperature on IFN-
activity was compared to its effect on IFN-
and IFN-ß. Mouse B-16 melanoma cells were simultaneously cultured under cloning conditions at a range of temperatures (37.3, 38.1, 38.6, and 39.4°C) in the presence of MuIFN-
, MuIFN-ß, and MuIFN-
. The antiproliferative activities of all three interferons were enhanced by incubation at the elevated temperatures. However, the elevated temperatures had a more dramatic enhancing effect on the antiproliferative activity of MuIFN-
(10-fold enhancement) than of either MuIFN-
or MuIFN-ß (2.9- and 3.4-fold enhancement, respectively). Next, the enhancing effect of elevated temperature (39.4°C) was examined for a range of interferon concentrations. The degree of the enhancing effect increased with increasing concentrations of MuIFN-
but not with increasing concentrations of MuIFN-
or MuIFN-ß. Enhancing effects of temperature as high as 14-fold were observed for 100 units of MuIFN-
/ml. This dramatic enhancement was observed for both natural and recombinant MuIFN-
and was neither a function of greater relative perception of MuIFN-
titer at elevated temperature nor a function of greater relative stability of MuIFN-
at the elevated temperature. The differential enhancement of MuIFN-
activity by elevated temperature appeared to be specific for the antiproliferative activity, since the antiviral activity of MuIFN-
was not relatively more enhanced at 39.4°C than were the antiviral activities of MuIFN-
and MuIFN-ß. These results suggest that fever may be an important factor in maximizing the antitumor effects of MuIFN-
and perhaps of human IFN-
. They also raise the possibility that a combination treatment regimen of hyperthermia and interferon therapy, particularly IFN-
therapy, may provide a significant antitumor effect.
1 Supported by USPHS Grant CA26475 awarded by the National Cancer Institute, Department of Health and Human Services.
2 To whom requests for reprints should be addressed, at Department of Microbiology, The University of Texas Medical Branch, Galveston, TX 77550.
Received 4/18/85. Revised 9/ 3/85. Accepted 9/16/85.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |